Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid

Experimental and Molecular Medicine

Volumn 46, Issue 12, 2014, Pages

  Han, Songyi ^a   Huh, Jeongsoon ^a   Kim, Wooseong ^a   Jeong, Seongkeun ^a   Min, Do Sik ^a   Jung, Yunjin ^a  

^a Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BUTANOL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; VASCULOTROPIN; EPIDERMAL GROWTH FACTOR; VASCULOTROPIN A;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GLIOMA; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; SIGNAL TRANSDUCTION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923853614     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2014.86     Document Type: Article

References (27)

1. Exton JH. Regulation of phospholipase D. Biochim Biophys Acta 1999; 1439: 121-133
2. Zaremberg V, McMaster CR. Differential partitioning of lipids metabolized by separate yeast glycerol-3-phosphate acyltransferases reveals that phospholipase D generation of phosphatidic acid mediates sensitivity to cholinecontaining lysolipids and drugs. J Biol Chem 2002; 277: 39035-39044
3. Kang DW, Choi KY, Min do S. Phospholipase D meets Wnt signaling: A new target for cancer therapy. Cancer Res 2011; 71: 293-297
4. Gomez-Cambronero J. Phosphatidic acid, phospholipase D and tumorigenesis. Adv Biol Regul 2014; 54: 197-206
5. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001; 294: 1942-1945
6. Ktistakis NT, Delon C, Manifava M, Wood E, Ganley I, Sugars JM. Phospholipase D1 and potential targets of its hydrolysis product, phosphatidic acid. Biochem Soc Trans 2003; 31: 94-97
7. Foster DA. Regulation of mTOR by phosphatidic acid? Cancer Res 2007; 67: 1-4
8. Zheng Y, Rodrik V, Toschi A, Shi M, Hui L, Shen Y et al. Phospholipase D couples survival and migration signals in stress response of human cancer cells. J Biol Chem 2006; 281: 15862-15868
9. Shi M, Zheng Y, Garcia A, Xu L, Foster DA. Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. Cancer Lett 2007; 258: 268-275
10. Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997; 272: 22642-22647
11. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; 2007: cm8
12. Fandrey J. Erythropoiesis-once more HIF!. Blood 2008; 112: 931-932
13. Li QF, Dai AG. Hypoxia inducible factor-1 alpha correlates the expression of heme oxygenase 1 gene in pulmonary arteries of rat with hypoxia-induced pulmonary hypertension. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 133-140
14. Brune B, Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr Med Chem 2003; 10: 845-855
15. Choi KS, Bae MK, Jeong JW, Moon HE, Kim KW. Hypoxia-induced angiogenesis during carcinogenesis. J Biochem Mol Biol 2003; 36: 120-127
16. Bardos JI, Ashcroft M. Hypoxia-inducible factor-1 and oncogenic signalling. Bioessays 2004; 26: 262-269
17. Gomez-Cambronero J. New concepts in phospholipase D signaling in inflammation and cancer. ScientificWorldJournal 2010; 10: 1356-1369
18. Park MH, Ahn BH, Hong YK, Min do S. Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis 2009; 30: 356-365
19. Matsumoto Y. Base excision repair in mammalian cells. Methods Mol Biol 2006; 314: 365-375
20. Kim J, Choi BH, Jang KL, Min DS. Phospholipase D activity is elevated in hepatitis C virus core protein-transformed NIH3T3 mouse fibroblast cells. Exp Mol Med 2004; 36: 454-460
21. Asnaghi L, Bruno P, Priulla M, Nicolin A. mTOR: A protein kinase switching between life and death. Pharmacol Res 2004; 50: 545-549
22. Toschi A, Edelstein J, Rockwell P, Ohh M, Foster DA. HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D. Oncogene 2008; 27: 2746-2753
23. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472
24. Lu Z, Hornia A, Joseph T, Sukezane T, Frankel P, Zhong M et al. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Mol Cell Biol 2000; 20: 462-467
25. Lee CS, Kim KL, Jang JH, Choi YS, Suh PG, Ryu SH. The roles of phospholipase D in EGFR signaling. Biochim Biophys Acta 2009; 1791: 862-868
26. Hornberger TA, Chu WK, Mak YW, Hsiung JW, Huang SA, Chien S. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci USA 2006; 103: 4741-4746
27. Cho D, Signoretti S, Regan M, Mier JW, Atkins MB. The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer. Clin Cancer Res 2007; 13: 758s-763s.